Article Information
- Received December 23, 2006
- Revision received February 21, 2008
- Accepted February 25, 2008
- First published April 2, 2008.
- Version of record published April 2, 2008.
Author Information
- Correspondence should be addressed to Laurent Roybon, Neuronal Survival Unit, Division for Neuroscience, Department of Experimental Medical Science, Wallenberg Neuroscience Center, BMC A10, 221 84 Lund, Sweden. laurent.roybon{at}med.lu.se
Author contributions
-
↵*L.R. and T.H. contributed equally to this work.
Disclosures
- Received December 23, 2006.
- Revision received February 21, 2008.
- Accepted February 25, 2008.
-
This work was supported by NeuroFortis, Thorsten och Elsa Segerfalks Stiftelse, Swedish Research Council, the Swedish Parkinson Foundation, Torsten och Ragnar Söderbergs stiftelser, Konung Gustaf V:s och Drottning Victorias Stiftelse, and the Swedish Brain Foundation. L.R. was supported by the European Commission through the Framework Program 6 project STEMS (LHSB-CT-2006-037328), and N.S.C. is sponsored by Lundbeckfonden (Grant R7-A686). We thank Profs. J. Ericson and T. Perlmann (Karolinska Institute, Stockholm, Sweden), Prof. J. Song (Cell and Gene Therapy Research Institute, Pochon, Korea), and Prof. J. Frisén (Karolinska Institute, Stockholm, Sweden) for providing us with certain cDNA and some of the retrovirus constructs. We thank Profs. M. P. Smidt, M. German, and R. G. Lindahl for their generous gift of antibodies, Birgit Haraldsson, Britt Lindberg, and Marianne Rissler for excellent technical assistance, and Birgitta Larsson for her help in grant administration.
- Correspondence should be addressed to Laurent Roybon, Neuronal Survival Unit, Division for Neuroscience, Department of Experimental Medical Science, Wallenberg Neuroscience Center, BMC A10, 221 84 Lund, Sweden. laurent.roybon{at}med.lu.se
Online Impact